Brief: Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
07/02/2025 21:08
Feb 7 (Reuters) - NewAmsterdam Pharma Company NV
KH6.F :
* NEWAMSTERDAM PHARMA REPORTS INDUCEMENT GRANTS UNDER NASDAQ
LISTING RULE 5635(C)(4)
Source text: ID:nGNX4r589z
Further company coverage: KH6.F
((reuters.briefs@thomsonreuters.com;))
Recent news on NewAmsterdam Pharma
See all newsBrief: Menarini Group & Newamsterdam Pharma Receive European Commission Approval For Ubeslo And Evlarco
Amgen falls after Novartis trial setback, BMO downgrade
Brief: Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Newamsterdam Pharma Company N.V. - Announces Positive CHMP Opinion For Obicetrapib And Obicetrapib/Ezetimibe
Brief: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)